We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

87 hedge funds and large institutions have $19.5M invested in Zomedica Corp. in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less capital invested

Capital invested by funds: $20.8M → $19.5M (-$1.35M)

10% less funds holding

Funds holding: 97 → 87 (-10)

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
87
Holders Change
-10
Holders Change %
-10.31%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
19
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$596K
2
VF
Virtu Financial
New York
+$81.4K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$58.3K
4
EDRH
Edmond de Rothschild Holding
Switzerland
+$26.5K
5
TSS
Two Sigma Securities
New York
+$25.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$395K
2
GCP
GSA Capital Partners
United Kingdom
-$280K
3
Jane Street
Jane Street
New York
-$243K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$128K
5
Millennium Management
Millennium Management
New York
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$9.78M +$596K +2,252,651 +5%
BlackRock
2
BlackRock
New York
$2.39M -$8.66K -32,718 -0.3%
Cambridge Investment Research Advisors
3
Cambridge Investment Research Advisors
Iowa
$2.36M +$5.29K +20,000 +0.2%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.89M +$2.76K +10,417 +0.1%
State Street
5
State Street
Massachusetts
$704K – – –
BBHC
6
Brown Brothers Harriman & Co
New York
$482K – – –
Northern Trust
7
Northern Trust
Illinois
$354K – – –
PWMG
8
Pinnacle Wealth Management Group
Michigan
$247K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$214K -$395K -1,492,000 -60%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$123K – – –
VF
11
Virtu Financial
New York
$122K +$81.4K +307,820 +114%
Charles Schwab
12
Charles Schwab
California
$73K – – –
Morgan Stanley
13
Morgan Stanley
New York
$59K -$74.1K -280,009 -50%
GT
14
Glenmede Trust
Pennsylvania
$51K – – –
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$47K +$1.92K +7,250 +3%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$46K +$58.3K +220,286 New
UBS Group
17
UBS Group
Switzerland
$44K +$22.7K +85,736 +69%
SCA
18
Snowden Capital Advisors
New York
$40K – – –
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$40K – – –
Jane Street
20
Jane Street
New York
$35K -$243K -916,676 -85%
Millennium Management
21
Millennium Management
New York
$34K -$105K -398,663 -71%
TSS
22
Two Sigma Securities
New York
$26K +$25.5K +96,429 +356%
Victory Capital Management
23
Victory Capital Management
Texas
$23K -$6.11K -23,098 -17%
EDRH
24
Edmond de Rothschild Holding
Switzerland
$21K +$26.5K +100,000 New
GPFA
25
Game Plan Financial Advisors
Ohio
$19K -$9.26K -35,000 -28%
1
2 3 4

ZOM Hedge Fund Activity: Q3 2022 in Review

87 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2022, worth a combined $19.5M — down 6.5% from $20.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ZOM and 8 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 17 added.

The largest buyer was Vanguard Group, adding an estimated $596K. The largest seller was Renaissance Technologies, cutting an estimated $395K.

  • 87 institutional investors held Zomedica Corp. (ZOM) as of Q3 2022, down from 97 in Q2 2022.
  • Funds reported $19.5M of Zomedica Corp. stock for Q3 2022, down 6.5% quarter-over-quarter.
  • 8 funds opened new Zomedica Corp. positions in Q3 2022 and 16 closed out, a net change of -8 holders.
  • The largest Zomedica Corp. buyer in Q3 2022 was Vanguard Group, an estimated $596K added.
  • The largest Zomedica Corp. seller in Q3 2022 was Renaissance Technologies, an estimated $395K sold.

Based on aggregated 13F filings for Q3 2022.